Waystar targets low double-digit revenue growth, 40%+ adjusted EBITDA margin in long-term model

• Waystar outlined a strategy to push revenue-cycle management toward an “autonomous” model using data and AI-driven workflow automation.
• Market sizing highlighted USD 103.3 billion in total U.S. healthcare RCM spend, including USD 21 billion for RCM software.
• Segment total addressable market for services and software was put at USD 44.1 billion.
• Long-term model targets low double-digit revenue growth, adjusted EBITDA margin above 40%, supported by free cash flow generation.
• Capital allocation priorities include organic investment, debt reduction, share repurchases, disciplined M&A, dividends when appropriate.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Waystar Holding Corp. published the original content used to generate this news brief on August 26, 2026, and is solely responsible for the information contained therein.